These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 22840327)

  • 1. Possible therapeutic potential of berberine in diabetic osteopathy.
    Rahigude AB; Kaulaskar SV; Bhutada PS
    Med Hypotheses; 2012 Oct; 79(4):440-4. PubMed ID: 22840327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amelioration effects of berberine on diabetic microendothelial injury model by the combination of high glucose and advanced glycation end products in vitro.
    Hao M; Li SY; Sun CK; Jingyu-Xu ; Lin Y; Liu KX; Wang L; Li CX; Zhou Q; Du JL; Li H
    Eur J Pharmacol; 2011 Mar; 654(3):320-5. PubMed ID: 21236251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible therapeutic potential of berberine in the treatment of STZ plus HFD-induced diabetic osteoporosis.
    Xie H; Wang Q; Zhang X; Wang T; Hu W; Manicum T; Chen H; Sun L
    Biomed Pharmacother; 2018 Dec; 108():280-287. PubMed ID: 30223099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible participation of advanced glycation end products in the pathogenesis of osteoporosis in diabetic patients.
    Yamagishi S; Nakamura K; Inoue H
    Med Hypotheses; 2005; 65(6):1013-5. PubMed ID: 16146671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pioglitazone-induced bone loss in diabetic rats and its amelioration by berberine: A portrait of molecular crosstalk.
    Adil M; Mansoori MN; Singh D; Kandhare AD; Sharma M
    Biomed Pharmacother; 2017 Oct; 94():1010-1019. PubMed ID: 28810524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetes mellitus a risk for osteoporosis?
    Leidig-Bruckner G; Ziegler R
    Exp Clin Endocrinol Diabetes; 2001; 109 Suppl 2():S493-514. PubMed ID: 11460594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new concept underlying stem cell lineage skewing that explains the detrimental effects of thiazolidinediones on bone.
    Bruedigam C; Eijken M; Koedam M; van de Peppel J; Drabek K; Chiba H; van Leeuwen JP
    Stem Cells; 2010 May; 28(5):916-27. PubMed ID: 20213769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preventive effects of berberine on glucocorticoid-induced osteoporosis in rats.
    Xu D; Yang W; Zhou C; Liu Y; Xu B
    Planta Med; 2010 Nov; 76(16):1809-13. PubMed ID: 20577944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of diabetes and its treatments on skeletal diseases.
    Yan W; Li X
    Front Med; 2013 Mar; 7(1):81-90. PubMed ID: 23377889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection of cholinergic and antioxidant system contributes to the effect of berberine ameliorating memory dysfunction in rat model of streptozotocin-induced diabetes.
    Bhutada P; Mundhada Y; Bansod K; Tawari S; Patil S; Dixit P; Umathe S; Mundhada D
    Behav Brain Res; 2011 Jun; 220(1):30-41. PubMed ID: 21262264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes and bone health.
    Antonopoulou M; Bahtiyar G; Banerji MA; Sacerdote AS
    Maturitas; 2013 Nov; 76(3):253-9. PubMed ID: 23628280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral administration of quercetin inhibits bone loss in rat model of diabetic osteopenia.
    Liang W; Luo Z; Ge S; Li M; Du J; Yang M; Yan M; Ye Z; Luo Z
    Eur J Pharmacol; 2011 Nov; 670(1):317-24. PubMed ID: 21914440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Berberine improves free-fatty-acid-induced insulin resistance in L6 myotubes through inhibiting peroxisome proliferator-activated receptor gamma and fatty acid transferase expressions.
    Chen Y; Li Y; Wang Y; Wen Y; Sun C
    Metabolism; 2009 Dec; 58(12):1694-702. PubMed ID: 19767038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ameliorative effect of berberine on renal damage in rats with diabetes induced by high-fat diet and streptozotocin.
    Wu D; Wen W; Qi CL; Zhao RX; Lü JH; Zhong CY; Chen YY
    Phytomedicine; 2012 Jun; 19(8-9):712-8. PubMed ID: 22483555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Berberine promotes osteoblast differentiation by Runx2 activation with p38 MAPK.
    Lee HW; Suh JH; Kim HN; Kim AY; Park SY; Shin CS; Choi JY; Kim JB
    J Bone Miner Res; 2008 Aug; 23(8):1227-37. PubMed ID: 18410224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current perspectives on parathyroid hormone (PTH) and PTH-related protein (PTHrP) as bone anabolic therapies.
    Esbrit P; Alcaraz MJ
    Biochem Pharmacol; 2013 May; 85(10):1417-23. PubMed ID: 23500550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opposing effects of bisphosphonates and advanced glycation end-products on osteoblastic cells.
    Gangoiti MV; Cortizo AM; Arnol V; Felice JI; McCarthy AD
    Eur J Pharmacol; 2008 Dec; 600(1-3):140-7. PubMed ID: 18973752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of oxidative stress in diabetic bone disorder.
    Hamada Y; Fujii H; Fukagawa M
    Bone; 2009 Jul; 45 Suppl 1():S35-8. PubMed ID: 19232402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Osteoporosis in diabetes].
    Kumeda Y
    Clin Calcium; 2008 May; 18(5):589-99. PubMed ID: 18445876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parathyroid hormone may maintain bone formation in hibernating black bears (Ursus americanus) to prevent disuse osteoporosis.
    Donahue SW; Galley SA; Vaughan MR; Patterson-Buckendahl P; Demers LM; Vance JL; McGee ME
    J Exp Biol; 2006 May; 209(Pt 9):1630-8. PubMed ID: 16621944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.